Sphera Funds Management Ltd. Praxis Precision Medicines, Inc. Transaction History

Sphera Funds Management Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.87 - $22.97 $3.93 Million - $104 Million	-4,521,331 Reduced 93.22%	328,986 $7.33 Million
Q3 2023 Nov 14, 2023	SELL	$0.87 - $1.71 $3.41 Million - $6.69 Million	-3,914,017 Reduced 44.66%	4,850,317 $8.29 Million
Q2 2023 Aug 14, 2023	BUY	$0.83 - $1.18 $7.27 Million - $10.3 Million	8,764,334 New	8,764,334 $10.1 Million
Q3 2021 Nov 15, 2021	SELL	$13.15 - $22.56 $994,140 - $1.71 Million	-75,600 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$18.28 - $33.05 $1.38 Million - $2.5 Million	75,600 New	75,600 $1.38 Million
Q1 2021 May 17, 2021	SELL	$29.34 - $60.2 $2.93 Million - $6.02 Million	-100,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$27.25 - $55.82 $2.73 Million - $5.58 Million	100,000 New	100,000 $5.5 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.35B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.